日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Production of 5‑Hydroxymethylfurfural from Glucose under Hydrothermal Conditions

水热条件下葡萄糖制备5-羟甲基糠醛

Tian, Haojie; Li, Sichan; Zhou, Mengli; Zhu, Tingyu; Liu, Xinyu; Wu, Zhimin; Liu, Qiying; Jiang, Jianchun

Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy.

基于癫痫患儿发育和遗传特征的氯巴占群体药代动力学和模型指导的精准给药

Tuo Yali, Yu Xiaolong, Li Sichan, Wang Jun, Liu Maochang, Song Xinwen, Ma Jiehui, Wang Yang, Liu Zhisheng, Sun Dan

Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects

针对新冠病毒的新型抗病毒药物ASC10在中国健康受试者中的群体药代动力学模型分析

Lv, Duo; Li, Sichan; Li, Yi; Lin, Meihua; Zhai, You; Wu, Meijia; Qiu, Yunqing; Zhao, Qingwei; Liu, Jian

Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders

CYP2D6 和 ABCB1 多态性对阿立哌唑治疗儿童抽动障碍的药代动力学和疗效的影响

Xin, Yingying; Gao, Liuliu; Li, Sichan; Wang, Jun; Chen, Chen; Tuo, Yali; Nie, Gang; Li, Ruizhen; Sun, Dan; Fu, Yongli; Wang, Yang; Liu, Zhisheng

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children

头孢他啶在危重儿童中的群体药代动力学和剂量优化

Li, Mengting; Gao, Liuliu; Wang, Zuo; Zeng, Lingkong; Chen, Chen; Wang, Jun; Li, Sichan; Liu, Maochang; Wang, Yang

Ornidazole Transfer into Colostrum and Assessment of Exposure Risk for Breastfeeding Infant: A Population Pharmacokinetic Analysis

奥硝唑向初乳的转移及母乳喂养婴儿暴露风险评估:一项群体药代动力学分析

Li, Sichan; Cao, Ming; Zhou, Yan; Shu, Chang; Wang, Yang

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children

拉他莫昔夫在中国儿童中的群体药代动力学和给药方案优化

Wang, Yang; Sun, Dan; Mei, Yan; Wu, Sanlan; Li, Xinlin; Li, Sichan; Wang, Jun; Gao, Liuliu; Xu, Hua; Tuo, Yali

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes

了解阿立哌唑在患有抽动障碍的儿童中的药代动力学/药效学个体差异:基于生理发育和CYP2D6基因型的个体化给药

Xin, Yingying; Gao, Liuliu; Tuo, Yali; Nie, Gang; Mei, Yan; Chen, Chen; Wang, Jun; Li, Sichan; Sun, Dan; Qian, Qiaoqiao; Fu, Yongli; Wang, Yang; Liu, Zhisheng

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization

应用群体药代动力学分析表征伏立康唑CYP2C19介导的代谢机制并支持剂量优化

Li, SiChan; Wu, SanLan; Gong, WeiJing; Cao, Peng; Chen, Xin; Liu, Wanyu; Xiang, Liping; Wang, Yang; Huang, JianGeng

How Much Vancomycin Dose Is Enough For The MRSA Infection in Pediatric Patients With Various Degrees of Renal Function?

对于肾功能状况各异的儿科患者,治疗耐甲氧西林金黄色葡萄球菌(MRSA)感染需要多少万古霉素剂量?

Wang Yang, Gao Ping, Zhang Huanian, Chen Yujun, Niu Changhe, Liu Maochang, Li Sichan, Xu Qiong, Ye Qi